Fig. 4From: Endothelial Permeability and the Angiopoietin/Tie2 System Following Mild and Severe COVID-19Endothelial barrier function with recombinant angiopoietin-1 Human pulmonary (A) and renal (B) endothelial cells were exposed to plasma from mild (ward; grey lines) and severe (ICU; black lines) COVID-19 patients collected at admission and treated with recombinant angiopoietin-1 (rAng1; dotted lines). Data represent meanBack to article page